Canine C-Reactive Protein (cCRP)
Canine C-reactive protein is a major acute-phase protein; quantitative measurement supports detection and serial monitoring of systemic inflammation.
Fact Table
| Species | Canine |
|---|---|
| Biomarker | C-reactive protein (CRP) |
| Method | Fluorescence immunoassay (FICT) |
| Unit | mg/L |
| Category | Inflammatory |
Clinical Context
Canine C-reactive protein is a major acute-phase protein; quantitative measurement supports detection and serial monitoring of systemic inflammation.
Interpretation should always combine the quantitative result with the patient's signalment, history, clinical signs, and any other laboratory findings. A single value is rarely diagnostic on its own; serial measurements often provide more useful information.
Reference Range
Reference ranges vary by species, age and laboratory method — always interpret against the kit IFU and your in-house validation.
Related Test Kits
Related Articles
Manufacturer documentation + clinical literature cited in related articles
2026-09-12
MEDIUM — reference ranges are method-specific
FAQ
What does the Canine C-Reactive Protein (cCRP) test measure?
Migibio's Canine C-Reactive Protein (cCRP) test is a quantitative fluorescence immunoassay (FICT) run on the FIA680/FIA880 analyzer. It is intended as an aid in clinical assessment: Canine C-reactive protein is a major acute-phase protein; quantitative measurement supports detection and serial monitoring of systemic inflammation. The exact specimen, sample handling, and reporting units are specified in the kit IFU.
When is canine CRP testing most useful?
When systemic inflammation is suspected or to monitor response to treatment, surgery, or infection. A baseline and serial measurements help distinguish resolving from persistent inflammation. For dogs, use the result with the clinical history, physical examination, and any other laboratory findings.
Why does this Data Hub not publish a universal reference range?
Reference ranges vary by species, age and laboratory method — always interpret against the kit IFU and your in-house validation.